Profound Medical Corp.

TSX:PRN.TO

Medical - Devices

Healthcare
$9.83 +1.18%

+$0.11 today

Market cap
$360.04M
Beta
0.52
P/E (TTM)
-6.3
EPS (TTM)
-$1.07
52W Low $5.23High $12.40

Volume 0.00M

Average 0.01M

PRN.TO Other Income / Expenses

Net non-operating gains and losses, such as investment results, currency effects, and one-off items.

Profound Medical Corp.TSX: PRN.TO

Other Income / Expenses · Q1 FY2026 · quarter ended Mar 2026

Other income / expenses growth accelerates

Q1 FY2026 other income / expenses of $976.73K rose 102.2% year over year, ahead of the -113.5% change in trailing-twelve-month other income / expenses.

Context

  • Other income / expenses amounted to 6.6% of revenue in FY2025, down 42.5 pp from a year earlier.
  • Other income / expenses increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +102.2% holds above the trailing-twelve-month pace of -113.5%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$976.73K+223.3% QoQ
Last fiscal yearDec 2025
-$1.08M-120.6% YoY
LTMMar 2026
-$594.98K-113.5% YoY
Other Income / Expenses past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+102.2%——
1 year-120.6%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Other Income / Expenses history

USD · from the income statement

Latest · FY2025
(1.08M) USD
Year-over-year change
-120.6%

Other Income / Expenses vs competitors

How PRN.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so other income / expenses is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -113.5% is the lowest of 6, against a peer median of +14.9%.
  • Other income / expenses amounts to 3.2% of revenue for PRN.TO, versus a peer median of 4.3%.
PRN.TO Competitors
Other Income / Expenses for PRN.TO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
XLY.TOAuxly Cannabis Group Inc.LTM Mar 2026CA$10.6M CAD+210.4%—6.7%
EPRX.TOEupraxia Pharmaceuticals Inc.LTM Mar 2026$2.87M USD-20.1%——
DR.TOMedical Facilities CorporationLTM Mar 2026$1.9M USD+130.1%—0.6%
PRN.TOProfound Medical Corp.LTM Mar 2026-$594.98K USD-113.5%—3.2%
HLS.TOHLS Therapeutics Inc.LTM Mar 2026-$6.61M USD+11.8%—11.9%
CRRX.TOCareRx CorporationLTM Mar 2026-CA$7.23M CAD+14.9%—1.9%
Peer median (excluding PRN.TO) —+14.9%—4.3%

Competitors are the stored peer set for PRN.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue6.87M6.68M7.2M10.68M16.38M
Cost of Revenue3.92M3.66M2.82M3.64M4.79M
Gross Profit2.95M3.02M4.38M7.04M11.59M
Gross Margin43.0%45.2%60.9%65.9%70.8%
Research & Development15.28M14.69M14.38M16.97M20.96M
Selling, General & Admin17.97M17.93M18.62M23.13M32.61M
Operating Expenses33.24M32.62M33M40.1M53.57M
Depreciation & Amortization1.88M1.6M929K936K569.8K
EBITDA(28.65M)(26.6M)(27M)(32.13M)(41.41M)
EBITDA Margin-416.8%-398.2%-375.0%-300.8%-252.8%
Operating Income(30.29M)(29.6M)(28.62M)(33.06M)(41.98M)
Operating Margin-440.7%-443.1%-397.5%-309.6%-256.3%
Interest Income205K1.06M1.64M1.44M1.09M
Interest Expense67K168.82K770K00
Other Income / Expenses(303K)1.22M200K5.24M(1.08M)
Income Before Tax(30.59M)(28.38M)(28.7M)(27.82M)(43.06M)
Pre-Tax Margin-445.1%-424.8%-398.6%-260.5%-262.9%
Income Tax Expense105K287K(128K)(2K)256.41K
Net Income(30.7M)(28.67M)(28.57M)(27.82M)(43.32M)
Net Margin-446.7%-429.1%-396.8%-260.4%-264.4%
EPS (Basic)(1.50)(1.38)(1.35)(1.12)(1.43)
EPS (Diluted)(1.50)(1.38)(1.35)(1.12)(1.43)
Weighted Avg Shares20.46M20.77M21.18M24.77M30.23M
Weighted Avg Shares (Diluted)20.47M20.77M21.18M24.77M30.23M

Profound Medical Corp.

TSX:PRN.TO

Intrinsic Alpha fair value

Locked

Current Price

$9.83

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.